Enliven Therapeutics Stock Price History

ELVN Stock   21.08  0.16  0.76%   
Below is the normalized historical share price chart for Enliven Therapeutics extending back to March 12, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enliven Therapeutics stands at 21.08, as last reported on the 22nd of March, with the highest price reaching 21.41 and the lowest price hitting 20.55 during the day.
IPO Date
200 Day MA
23.4758
50 Day MA
21.3664
Beta
1.146
 
Covid
If you're considering investing in Enliven Stock, it is important to understand the factors that can impact its price. Enliven Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0387, which denotes the company had a -0.0387 % return per unit of risk over the last 3 months. Enliven Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enliven Therapeutics' Variance of 10.89, standard deviation of 3.3, and Mean Deviation of 2.4 to check the risk estimate we provide.
  
At this time, Enliven Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 22nd of March 2025, Sale Purchase Of Stock is likely to grow to 1,208, while Issuance Of Capital Stock is likely to drop about 27.4 M. . At this time, Enliven Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 22nd of March 2025, Price Earnings To Growth Ratio is likely to grow to 2.09, while Price Earnings Ratio is likely to drop (12.49). Enliven Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0387

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsELVN

Estimated Market Risk

 3.18
  actual daily
28
72% of assets are more volatile

Expected Return

 -0.12
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Enliven Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enliven Therapeutics by adding Enliven Therapeutics to a well-diversified portfolio.
Price Book
3.3324
Book Value
6.332
Enterprise Value
740.8 M
Enterprise Value Ebitda
(6.28)
Shares Float
26.9 M

Enliven Therapeutics Stock Price History Chart

There are several ways to analyze Enliven Stock price data. The simplest method is using a basic Enliven candlestick price chart, which shows Enliven Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 3, 202524.43
Lowest PriceMarch 3, 202519.62

Enliven Therapeutics March 22, 2025 Stock Price Synopsis

Various analyses of Enliven Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Enliven Stock. It can be used to describe the percentage change in the price of Enliven Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Enliven Stock.
Enliven Therapeutics Price Daily Balance Of Power 0.19 
Enliven Therapeutics Price Rate Of Daily Change 1.01 
Enliven Therapeutics Price Action Indicator 0.18 

Enliven Therapeutics March 22, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Enliven Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Enliven Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Enliven Stock and then apply it to test your longer-term investment strategies against Enliven.

Enliven Stock Price History Data

The price series of Enliven Therapeutics for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 4.81 with a coefficient of variation of 5.22. Under current investment horizon, the daily prices are spread out with arithmetic mean of 21.82. The median price for the last 90 days is 21.82. The company completed 1:4 stock split on 24th of February 2023.
OpenHighLowCloseVolume
03/22/2025
 20.64  21.41  20.55  21.08 
03/21/2025 20.64  21.41  20.55  21.08  412,125 
03/20/2025 20.48  21.34  20.35  20.92  235,326 
03/19/2025 20.23  21.18  20.18  20.89  144,067 
03/18/2025 20.57  21.18  20.26  20.28  244,820 
03/17/2025 20.61  21.06  19.98  21.04  140,102 
03/14/2025 21.10  22.21  20.55  20.74  205,365 
03/13/2025 21.12  21.12  20.21  20.29  141,655 
03/12/2025 20.72  21.16  20.47  21.02  138,219 
03/11/2025 20.42  20.75  19.50  20.69  212,908 
03/10/2025 20.90  20.90  19.93  20.27  162,206 
03/07/2025 21.64  22.29  20.98  21.00  347,272 
03/06/2025 20.84  22.36  20.79  21.46  325,376 
03/05/2025 20.02  21.26  19.83  21.25  282,973 
03/04/2025 19.36  20.02  18.67  19.92  349,421 
03/03/2025 20.70  21.24  19.53  19.62  299,041 
02/28/2025 20.28  21.04  20.03  20.83  185,161 
02/27/2025 20.10  20.84  20.00  20.15  91,056 
02/26/2025 20.10  20.75  20.02  20.28  117,928 
02/25/2025 21.53  21.53  20.10  20.13  203,721 
02/24/2025 21.91  21.98  21.31  21.35  153,225 
02/21/2025 21.94  22.50  21.75  21.80  169,973 
02/20/2025 21.92  21.93  21.16  21.47  110,168 
02/19/2025 21.76  22.07  21.49  21.90  157,266 
02/18/2025 22.18  22.36  21.55  21.82  117,540 
02/14/2025 21.64  22.38  21.17  21.68  387,406 
02/13/2025 20.67  22.91  20.67  21.50  318,190 
02/12/2025 20.98  22.08  20.97  22.05  170,114 
02/11/2025 21.20  21.82  20.82  21.41  157,484 
02/10/2025 22.05  22.36  21.54  21.55  137,794 
02/07/2025 22.39  22.39  21.69  22.00  188,319 
02/06/2025 22.69  23.18  22.30  22.47  181,493 
02/05/2025 21.95  23.14  21.70  22.75  285,278 
02/04/2025 21.94  22.13  21.39  22.00  166,592 
02/03/2025 21.28  22.30  21.28  21.90  191,988 
01/31/2025 21.21  22.42  21.21  21.86  222,185 
01/30/2025 21.13  21.76  21.02  21.27  173,551 
01/29/2025 20.82  21.30  20.40  20.86  326,656 
01/28/2025 21.17  21.50  20.72  21.04  375,194 
01/27/2025 21.81  22.28  21.15  21.29  209,509 
01/24/2025 21.98  22.37  21.64  21.86  509,850 
01/23/2025 21.76  22.34  21.62  22.04  121,557 
01/22/2025 21.84  22.82  21.45  22.05  198,255 
01/21/2025 21.80  22.68  21.62  22.00  364,889 
01/17/2025 22.16  22.24  20.92  21.47  168,400 
01/16/2025 22.81  22.81  21.44  21.99  273,807 
01/15/2025 21.10  23.08  20.30  22.66  426,523 
01/14/2025 22.18  22.58  20.16  20.46  503,900 
01/13/2025 21.33  22.41  21.33  22.07  257,727 
01/10/2025 23.55  24.21  21.41  21.74  323,088 
01/08/2025 23.42  24.23  21.71  24.15  137,663 
01/07/2025 23.93  24.63  23.51  23.86  192,813 
01/06/2025 24.37  25.08  24.05  24.07  154,287 
01/03/2025 24.21  25.37  24.00  24.43  249,260 
01/02/2025 22.80  24.45  22.80  23.90  170,728 
12/31/2024 22.61  23.00  22.08  22.50  90,373 
12/30/2024 21.97  22.78  21.55  22.39  221,104 
12/27/2024 22.29  22.50  21.57  22.37  255,845 
12/26/2024 22.92  24.32  22.26  22.71  137,458 
12/24/2024 23.36  23.70  22.53  23.15  62,226 
12/23/2024 22.44  23.65  21.43  23.43  182,009 

About Enliven Therapeutics Stock history

Enliven Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enliven is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enliven Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enliven Therapeutics stock prices may prove useful in developing a viable investing in Enliven Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding47.1 M49.4 M
Net Loss-22.3 M-23.4 M

Enliven Therapeutics Quarterly Net Working Capital

302.21 Million

Enliven Therapeutics Stock Technical Analysis

Enliven Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Enliven Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Enliven Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Enliven Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Enliven Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Enliven Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enliven to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Enliven Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enliven Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enliven Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enliven Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enliven Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enliven Therapeutics. If investors know Enliven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enliven Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.90)
Return On Assets
(0.22)
Return On Equity
(0.32)
The market value of Enliven Therapeutics is measured differently than its book value, which is the value of Enliven that is recorded on the company's balance sheet. Investors also form their own opinion of Enliven Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enliven Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enliven Therapeutics' market value can be influenced by many factors that don't directly affect Enliven Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enliven Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enliven Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enliven Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.